**ACS management protocols of Kasr Al-Ainy University Hospital, one of the largest hospitals in Egypt and the Middle East, are presented**

In the face of the quickly evolving coronavirus disease 2019 (COVID-19) pandemic, many healthcare systems around the globe have modified their routine protocols for the management of patients presenting with acute cardiovascular emergencies including patients with acute coronary syndromes (ACS).^1,2^ A unifying theme in these new protocols is the adoption of new restrictive measures to meet the challenges of increased risk of infection of healthcare workers, limited numbers of beds, shortage of personal protective equipment (PPE), inadequate number of protected catheterization rooms, and the clinical overlap between ACS and COVID-19 infection in some of the patients.

In developing countries, with an already strained health system due to economic problems, the situation is more challenging and needs the formulation of efficient protocols that can accommodate several medical and socioeconomic challenges.

Egypt, with an estimated population of 100 million, is facing exceptional challenges during the COVID-19 crisis. Because the large-scale use of the polymerase chain reaction (PCR) test for SARS-CoV-2 in a large population is a problem, the prevalence of COVID-19 infection in Egypt is unknown. Furthermore, the supply of PPE falls far short of demands with lack of professionally protected cardiac catheterization rooms. With progression of the pandemic in such a large population, care of COVID-19 patients is expected to rapidly overwhelm the supplies, beds, and staff available in Egyptian hospitals.

Kasr Al-Ainy University Hospital is one of the largest tertiary referral centres in Egypt. With \>5200 beds in different departments, the hospital has become one of the major hot-spots for the COVID-19 pandemic. Still in the early phase of the epidemic, the cardiology service at the hospital is expected to face an unprecedented cutback in resources, with expected reduction of cardiac care unit (CCU) bed capacity and anticipated staff absences because of illness or self-isolation. Under these circumstances, the Cardiovascular Department in the hospital has revised the management protocols for ACS patients and implemented new management protocols for both patients with ST-segment elevation myocardial infarction (STEMI) and those with non-ST-segment elevation acute coronary syndromes (NSTE-ACS) (*Figures [1](#ehaa507-F1){ref-type="fig"}* and *[2](#ehaa507-F2){ref-type="fig"}*).

![Management protocols for ST-elevation myocardial infarction (STEMI). AVB, atrioventricular block; CA, coronary angiography; PCI, percutaneous coronary intervention; PCR, polymerase chain reaction; VT, ventricular tachycardia.](ehaa507f1){#ehaa507-F1}

![Management protocols for non-ST-segment elevation acute coronary syndromes (NSTE-ACS). CA, coronary angiography; CABG, coronary artery bypass surgery; CHF, congestive heart failure, CTn, cardiac troponin; DM, diabetes mellitus; EF, ejection fraction; GRACE, Global Registry of Acute Coronary Events; PCI, percutaneous coronary intervention; PCR, polymerase chain reaction.](ehaa507f2){#ehaa507-F2}

Management protocols were developed based on the following three principles:

i.  All patients presenting with ACS should be screened for possible COVID-19 infection. As outlined above, the prevalence of COVID-19 disease in Egypt remains unknown. Furthermore, COVID-19-infected patients may be asymptomatic or still in the incubation period with significant risk of transmission of the disease. Some patients, due to the media scare and fear of isolation, refrain from going to hospitals when they develop symptoms. For the same reasons, some patients may deny symptoms related to COVID-19 infection when they seek medical advice for other reasons. In the emergency room, all patients are screened for the presence of fever, respiratory symptoms, or history of contact with a suspected or confirmed COVID-19 patient. Suspected patients are admitted into isolation beds in the CCU where additional work-up for COVID-19 infection is performed including a PCR test. Other patients without initial suspicion for COVID-19 infection are admitted to the CCU where they are subjected to systematic evaluation for COVID-19 infection: fever chart, differential blood count, and pulmonary imaging. Patients with confirmed COVID infection, diagnosed either in the emergency room or during hospitalization, are transferred to specialized isolation facilities.

ii. Invasive interventions for ACS are offered only for high-risk ACS patients. Primary percutaneous coronary intervention (PCI) is recommended for high-risk STEMI patients (e.g. large infarction) and for patients with contraindications for fibrinolytic therapy. Since the COVID-19 status of these patients is not known, primary PCI should be performed with maximum staff protection in the safest possible environment. In other STEMI patients, a pharmaco-invasive strategy with initial fibrinolysis followed by coronary angiography within 2--24 h is recommended. In fibrinolysis-eligible patients, therapy should be initiated within 30 min, and patients should be monitored for clinical and electrocardiographic features of successful reperfusion within 90 min after fibrinolysis and, in cases of failed reperfusion, rescue PCI is recommended. It is acknowledged that primary PCI is the best reperfusion strategy for STEMI patients;^3^ however a pharmaco-invasive strategy may be the best compromise for our STEMI patients; this strategy would permit timely reperfusion for patients and allow time for a more systematic evaluation of COVID-19 status. Intracranial haemorrhage is a major safety concern in patients receiving fibrinolytic therapy; however, this risk is not expected to be significant because ACS tends to occur at a relatively young age among Egyptians.^4^ Among NSTE-ACS patients, an invasive strategy is offered only to high-risk patients and after clearance of ongoing COVID-19 infection. Patients at intermediate risk would be admitted based on the availability of CCU beds and the potential risk of getting COVID-19 infection while in the hospital.After PCI, patients are considered for early discharge within 24--48 h in order to ensure bed availability and to reduce patients' exposure within the hospital.

iii. It is imperative to rule out conditions that can mimic ACS in patients with active COVID-19 infection such as myocarditis, coronary spasm, Takotsubo cardiomyopathy, and pulmonary embolism. Integration of data derived from clinical examination, electrocardiogram, temporal change in cardiac troponin levels, and transthoracic echocardiography should help in making the proper diagnosis. In a group of critically ill patients presenting in shock or in severe respiratory distress or with electrical instability, the differentiation between an ischaemic aetiology for these conditions vs. COVID-related complication is challenging. These patients should be approached as presumptive COVID-19-positive patients with rapid simultaneous evaluation for COVID-19 infection and myocardial ischaemia. Patients with confirmed ACS should proceed immediately to coronary angiography.
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